Introduction Non-ST-elevation acute coronary syndrome (NSTE-ACS) represents a significant proportion of acute coronary syndrome (ACS) cases. While the absence of ST-elevation suggests less myocardial damage compared to ST-elevation myocardial infarction (STEMI), NSTE-ACS still carries substantial risks of adverse outcomes, including recurrent isch

Content Introduction The emergence of SARS-CoV-2 variants has raised global concerns regarding vaccine efficacy and the durability of immune protection. Recent studies have highlighted the potential of mRNA vaccine boosters to extend protection against evolving variants. This study explores the long-term immunity provided by a Phase II clinically